CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Henan Taloph Pharmaceutical Stock Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Henan Taloph Pharmaceutical Stock Co Ltd
No. 8
Jinsuo Road
Phone: +86 37167992262p:+86 37167992262 ZHENGZHOU, HEN  450001  China Ticker: 600222600222
Business Summary
Henan Taloph Pharmaceutical Stock Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company operates four segments. Pharmaceutical Manufacturing segment is mainly engaged in pharmaceutical preparations and Chinese herbal medicine slices business. Its products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Xiaoer Qingre Zhike oral liquid, Xiaoer Tuire oral liquid, Danshen oral liquid, Shengmaiyin, Fufang Yimu oral liquid, and various Chinese herbal medicine slices. Pharmaceutical and Medicinal Materials Circulation segment is mainly engaged in fresh processing business and traceable medicinal materials trading. Pharmaceutical Research and Development Services segment mainly provides technical services such as preclinical pharmaceutical research, clinical contract research organization (CRO) research, and registration application. Other segment is mainly engaged in investment business.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
8071 Medical laboratories
8731 Commercial physical and biological research
6282 Investment advice

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HuiYin 57 2/25/2022 2/25/2022
Vice Chairman of the Board, General Manager JingliangLi 54 6/25/2023
Vice Chairman of the Board HuiLi 50 2/25/2022
10 additional Officers and Directors records available in full report.

Business Names
Business Name
600222
Henan Joyline&Joysun Pharmaceutical
Henan Taloph Pharmaceutical Stock Co.,

General Information
Number of Employees: 2,353 (As of 12/31/2023)
Outstanding Shares: 573,886,283 (As of 9/30/2024)
Shareholders: 63,209
Stock Exchange: SHA
Fax Number: +86 37167993600


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024